Global Large Volume Parenteral (LVP) Market Projected to Grow at 9.4% CAGR, Reaching $19.38 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Large Volume Parenteral (LVP) Industry Market Size Be by 2025?
Significant expansion has been observed in the market for large volume parenterals (LVP) lately, projected to increase its value from $12.52 billion in 2024 to $13.53 billion in 2025, reflecting an 8.0% compound annual growth rate. This upward trajectory during the preceding years is linked to several key factors, including a greater incidence of long-term illnesses, the swelling demographic of older adults, escalating requirements for contamination-free medicinal products, the broadening of medical facilities, and the establishment of formalized guidelines governing pharmaceuticals.

What's the Long-Term Growth Forecast for the Large Volume Parenteral (LVP) Market Size Through 2029?
Projected for robust expansion, the market encompassing large volume parenterals (LVP) anticipates significant escalation, reaching a valuation of $19.38 billion by 2029, fueled by a compound annual growth rate (CAGR) of 9.4%; this upward trajectory in the anticipated timeframe is underpinned by several factors, notably the increasing requirement for biologics and their biosimilar counterparts, escalating global healthcare spending, the broadening scope of pharmaceutical outsourcing activities, a heightened emphasis on customized medical treatments, and the worldwide extension of drug distribution networks. Key developments expected to shape this sector during the forecast period encompass progress in production methodologies, the incorporation of cutting-edge technologies within drug manufacturing, the adoption of disposable system solutions, the creation of more concentrated medical preparations, and the growing utility of additive manufacturing in pharmaceutical contexts.

View the full report here:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

What Are the Key Growth Drivers Fueling the Large Volume Parenteral (LVP) Market Expansion?
The increasing incidence of long-term health conditions is anticipated to boost the expansion of the large-volume parenteral sector going forward. Such long-lasting ailments, characterized by a duration of three months or more and the potential for deterioration, are primarily caused by factors including tobacco exposure, secondhand smoke, and inadequate dietary intake. Individuals afflicted with these conditions necessitate a precise proportion of vital nutrients to sustain their vigor, and the parenteral route of delivery ensures the accurate dosing of medication since a significant portion is directly assimilated into the bloodstream, bypassing the gastrointestinal tract altogether. To illustrate this impact, data from the World Health Organization, the specialized UN body headquartered in Switzerland, indicated that in September 2023, non-communicable diseases, or chronic illnesses, were responsible for 41 million fatalities globally each year, accounting for a substantial 74 percent of all deaths, thus establishing the escalating frequency of chronic diseases as a key impetus for the growth observed in the large-volume parenteral market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

What Are the Key Trends Driving Large Volume Parenteral (LVP) Market Growth?
A significant movement within the sector for high-volume parenteral solutions involves a focus on novel product development. Leading participants in this marketplace are directing substantial resources toward designing new offerings to bolster their competitive standing. Illustratively, in March of 2022, SGD Pharma SA, a French entity specializing in primary pharmaceutical packaging made from molded and tubular glass, introduced sterile 100-ml Type I molded glass vials, designed for immediate aseptic filling and subsequent processing of parenteral drugs. This advancement aids in preventing surface abrasions on the vial, facilitates easier visual inspection of the sealed container, and consequently reduces the chances of rejection during final quality inspection stages.

How Is the Large Volume Parenteral (LVP) Market Segmented?
The large volume parenteral (lvp)market covered in this report is segmented -

1) By Type: Soft Bag LVP; Plastic Bag LVP; Glass Bottle LVP
2) By Volume: 100 ML - 250 ML; 250 ML - 500 ML; 500 ML - 1000 ML; 1000 ML -2000 ML; 2000 And More
3) By Application: Basic Infusion; Therapeutics Infusion; Nutritious Infusion
4) By End-User: Hospital; Medical Centers; Other End Users

Subsegments:
1) By Soft Bag LVP: PVC Soft Bags; Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags; Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles; Multi-Dose Glass Bottles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

Which Companies Are Leading the Charge in Large Volume Parenteral (LVP) Market Innovation?
Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton dic*kinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

Which Regions Are Leading the Global Large Volume Parenteral (LVP) Market in Revenue?
North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.